• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2009 Fiscal Year Final Research Report

Allograft Rejection by Nature Immunity which Consist of Allograft Induced Macrophages

Research Project

  • PDF
Project/Area Number 20791129
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeSingle-year Grants
Research Field Urology
Research InstitutionOsaka Medical College

Principal Investigator

NOMI Hayahito  Osaka Medical College, 医学部, 助教 (80418938)

Project Period (FY) 2008 – 2009
Keywordsマクロファージ / 同種異型移植 / 急性拒絶 / マウス / トラニラスト
Research Abstract

At first, we analyzed in tumor cells of allogeneic transplantation models, because it turned out to require more time beyond our expectation to achieve the clear result of suppressing macrophages from allogeneic organ transplantation mouse models. We have already reported that 3 × 10^6 cells Meth A fibro-sarcoma (MA cells) which were allo-transplantated into peritoneal space of a C57BL/6 mouse completely rejected in about 14 days. We have also reported that allograft-induced macrophages (AIM) were effective mainly as cellular disorder of peritoneal infiltrating which were activated in this rejection. MA cells have been known to be CTL resistant cells. In this study, we used GFP transgenic C57BL/6 mice (GFP-mice) for the donors and we finally succeeded in videotaping that the GFP-AIM were biting off the co-cultured allogeneic MA cells. We were sure that the bited off allo-MA cells from this achievement. But, we now have to solve the critical problems whether biting off abilities of the AIM are exert toward allogeneic or neoplastic changes of MA. Now we are examining the ability of AIM derived from PEC to solve this problem, after removing some AIM cells which can respond to neoplastic changes. In addition, we are investigating time course of fluorescence shift of the cells PEC drive adherent cells mainly consist from GFP-AIM with or without various concentration of some of agents influence to macrophage, like as Tranilast(3μM~300μM). We, however, have not found out critical effect of it yet. Next, we will try it in activation phase of AIM.

  • Research Products

    (2 results)

All 2008 Other

All Presentation (1 results) Remarks (1 results)

  • [Presentation] 1)大阪医科大学泌尿生殖・発達医学口座泌尿器科学教室2)大阪医科大学研究機構アロ活性化マクロファージによるアロ細胞への直接傷害機能の検証2008

    • Author(s)
      能見勇人1)、吉田龍太郎2)、小山耕 平1)、稲元輝生1)、右梅貴信1)、東治人1)、勝岡洋治1)
    • Organizer
      第19回泌尿器科分子・細胞研究会
    • Place of Presentation
      神戸ポートピアホテル
    • Year and Date
      2008-02-20
  • [Remarks] ホームページ等

URL: 

Published: 2011-06-18   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi